Paper published in a journal (Scientific congresses, symposiums and conference proceedings)
Discovery and pathogenicity assessment of neuropathology-associated gene variants
Neupert, Lisa-Marie; May, Patrick; Kobow, Katja et al.
2017In Epilepsia, 58 (Suppl.5), p. 174
Peer Reviewed verified by ORBi
 

Files


Full Text
2017-Epilepsia 170.pdf
Publisher postprint (45.13 kB)
Request a copy

All documents in ORBilu are protected by a user license.

Send to



Details



Keywords :
Neuropathology; Epilepsy; Variants
Abstract :
[en] Germline and brain-specific somatic variants have been reported as an underlying cause in patients with epilepsy-associated neuropathologies, including focal cortical dysplasias (FCDs) and long-term epilepsy associated tumors (LEAT). However, evaluation of identified neuropathology associated variants in genetic screens is complex since not all observed variants contribute to the etiology of neuropathologies not even in genuinely disease-associated genes. Here, we critically reevaluated the pathogenicity of 12 previously published disease-related genes and of 79 neuropathology-associated missense variants listed in the PubMed and ClinVar databases. We (1) assessed the evolutionary gene constraint using the pLI and the missense z score, (2) used the latest American College of Medical Genetics and Genomics (ACMG) guidelines, and (3) performed bioinformatic variant pathogenicity prediction analyses using PolyPhen-2, CADD and GERP. Constraint analysis classified only seven out of 12 genes to be likely disease-associated. Furthermore, 78 (89%) of 88 neuropathology-associated missense variants were classified as being of unknown significance (VUS) and only 10 (11%) as being likely pathogenic (LPII). Pathogenicity prediction yielded a discrimination between LPII variants and a discrimination for VUS compared with rare variant scores from individuals present in the Genome Aggregation Database (gnomAD). In summary, our results demonstrate that interpretation of variants associated with neuropathologies is complex while the application of current ACMG guidelines including bioinformatic pathogenicity prediction can help improving variant evaluation. Furthermore, we will augment this set of literature-identified variants at the conference by results from our variant screen using self-generated deep sequencing data in >150 candidate genes in >50 patients not yet analyzed.
Research center :
- Luxembourg Centre for Systems Biomedicine (LCSB): Bioinformatics Core (R. Schneider Group)
Disciplines :
Neurology
Genetics & genetic processes
Author, co-author :
Neupert, Lisa-Marie
May, Patrick  ;  University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB)
Kobow, Katja
Nothnagel, Michael
Nürnberg, Peter
Freiman, Thomas
Harter, Patrick
Klein, Karl-Martin
Weber, Yvonne
Blümcke, Ingmar
Lal, Dennis
External co-authors :
yes
Language :
English
Title :
Discovery and pathogenicity assessment of neuropathology-associated gene variants
Publication date :
08 December 2017
Event name :
32nd International Epilepsy Congress Barcelona
Event place :
Barcelona, Spain
Event date :
02-09-2017 5o 06-09-2017
Audience :
International
Journal title :
Epilepsia
ISSN :
1528-1167
Publisher :
Blackwell Science, Malden, United States - Massachusetts
Volume :
58
Issue :
Suppl.5
Pages :
S174
Peer reviewed :
Peer Reviewed verified by ORBi
Focus Area :
Systems Biomedicine
Available on ORBilu :
since 03 January 2018

Statistics


Number of views
93 (3 by Unilu)
Number of downloads
1 (1 by Unilu)

OpenCitations
 
17
WoS citations
 
0

Bibliography


Similar publications



Contact ORBilu